
Trauma
Transfusion unaffected despite lower blood loss with TXA in extracapsular fracture surgery
Bone Joint J. 2016 Jun;98-B(6):747-5375 patients with an unstable, extracapsular trochanteric hip fracture scheduled for intramedullary nail fixation were randomized to the procedure with and without the intravenous administration of tranexamic acid (TXA); the control group was instead treated with placebo saline. The purpose of this study was to determine if TXA was effective in reducing blood loss and transfusion rate in these patients. The results indicated that despite significantly lower blood loss observed in the TXA group, no significant difference between groups was observed in transfusion rate.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.